However, we conclude that high-altitude adapted Tibetan variants in the EGLN1 and possibly EPAS1 regions are associated with the modified lung cancer risk, and that the role of these Tibetan evolutionary selected haplotypes needs to be further elucidated. The gene discussed is EGLN1; the disease is lung cancer.